Docket

38471

Apotex Inc., et al. v. Schering Corporation, et al.

(Ontario) (Civil) (By Leave)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings

Date	Proceeding	Filed By (if applicable)
2019-06-04	Close file on Leave
2019-05-17	Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2019-05-17	Judgment on leave sent to the parties
2019-05-16	Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Court of Appeal for Ontario, Numbers C65118 and C65129, 2018 ONCA 890, dated November 8, 2018, is dismissed with costs. Dismissed, with costs
2019-04-08	All materials on application for leave submitted to the Judges, for consideration by the Court
2019-03-21	Certificate (on limitations to public access), (Letter Form), 23B-Reply to Sanofi	Apotex Inc.
2019-03-21	Certificate (on limitations to public access), (Letter Form), 23B-Reply to Schering	Apotex Inc.
2019-02-25	Applicant's reply to respondent's argument, (Book Form), Reply to Schering, Completed on: 2019-02-22	Apotex Inc.
2019-02-22	Applicant's reply to respondent's argument, (Book Form), Reply to Sanofi, Completed on: 2019-02-22	Apotex Inc.
2019-02-13	Notice of name, (Letter Form)	Schering Corporation
2019-02-13	Certificate (on limitations to public access), (Letter Form), 23B	Schering Corporation
2019-02-13	Certificate (on limitations to public access), (Letter Form), 23A	Schering Corporation
2019-02-13	Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2019-02-13	Schering Corporation
2019-02-12	Notice of name, (Letter Form)	Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc.
2019-02-12	Certificate (on limitations to public access), (Letter Form), 23B	Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc.
2019-02-12	Certificate (on limitations to public access), (Letter Form), 23A; Amended certificate required-rec'd 2019/02/19	Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc.
2019-02-12	Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2019-02-12	Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc.
2019-01-16	Correspondence received from, (Letter Form), Clarification re: counsel for Sanofi	Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc.
2019-01-14	Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED 2019/01/14
2019-01-11	Certificate (on limitations to public access), (Letter Form), 23B	Apotex Inc.
2019-01-07	Certificate (on limitations to public access), (Letter Form), 23A; Copy of sealing Order missing-rec'd 2019/01/11 Amended 23A rec'd 2019/02/25	Apotex Inc.
2019-01-07	Notice of name, (Letter Form)	Apotex Inc.
2019-01-07	Application for leave to appeal, (Book Form), (3 volumes), Missing: 23B-rec'd 2019/01/11, CA Order-rec'd 2019/01/11, Completed on: 2019-01-11	Apotex Inc.